These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32363153)

  • 1. Identification and ranking of important bio-elements in drug-drug interaction by Market Basket Analysis.
    Ferdousi R; Jamali AA; Safdari R
    Bioimpacts; 2020; 10(2):97-104. PubMed ID: 32363153
    [No Abstract]   [Full Text] [Related]  

  • 2. Positive-Unlabeled Learning for inferring drug interactions based on heterogeneous attributes.
    Hameed PN; Verspoor K; Kusljic S; Halgamuge S
    BMC Bioinformatics; 2017 Mar; 18(1):140. PubMed ID: 28249566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational prediction of drug-drug interactions based on drugs functional similarities.
    Ferdousi R; Safdari R; Omidi Y
    J Biomed Inform; 2017 Jun; 70():54-64. PubMed ID: 28465082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting and understanding comprehensive drug-drug interactions via semi-nonnegative matrix factorization.
    Yu H; Mao KT; Shi JY; Huang H; Chen Z; Dong K; Yiu SM
    BMC Syst Biol; 2018 Apr; 12(Suppl 1):14. PubMed ID: 29671393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data-driven prediction of adverse drug reactions induced by drug-drug interactions.
    Liu R; AbdulHameed MDM; Kumar K; Yu X; Wallqvist A; Reifman J
    BMC Pharmacol Toxicol; 2017 Jun; 18(1):44. PubMed ID: 28595649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo methods to assess pharmacokinetic drug- drug interactions in drug discovery and development.
    Lu C; Di L
    Biopharm Drug Dispos; 2020 Feb; 41(1-2):3-31. PubMed ID: 31778578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic and Static Simulations of Fluvoxamine-Perpetrated Drug-Drug Interactions Using Multiple Cytochrome P450 Inhibition Modeling, and Determination of Perpetrator-Specific CYP Isoform Inhibition Constants and Fractional CYP Isoform Contributions to Victim Clearance.
    Iga K
    J Pharm Sci; 2016 Mar; 105(3):1307-17. PubMed ID: 26886336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
    Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
    Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of drug-drug interaction in atrial fibrillation patients based on a large claims data.
    Momo K; Kobayashi H; Sugiura Y; Yasu T; Koinuma M; Kuroda SI
    PLoS One; 2019; 14(12):e0225297. PubMed ID: 31815956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis and prediction of drug-drug interaction by minimum redundancy maximum relevance and incremental feature selection.
    Liu L; Chen L; Zhang YH; Wei L; Cheng S; Kong X; Zheng M; Huang T; Cai YD
    J Biomol Struct Dyn; 2017 Feb; 35(2):312-329. PubMed ID: 26750516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TMFUF: a triple matrix factorization-based unified framework for predicting comprehensive drug-drug interactions of new drugs.
    Shi JY; Huang H; Li JX; Lei P; Zhang YN; Dong K; Yiu SM
    BMC Bioinformatics; 2018 Nov; 19(Suppl 14):411. PubMed ID: 30453924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-drug interaction discovery and demystification using Semantic Web technologies.
    Noor A; Assiri A; Ayvaz S; Clark C; Dumontier M
    J Am Med Inform Assoc; 2017 May; 24(3):556-564. PubMed ID: 28031284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of Drug-Drug Interactions by Using Profile Fingerprint Vectors and Protein Similarities.
    Dere S; Ayvaz S
    Healthc Inform Res; 2020 Jan; 26(1):42-49. PubMed ID: 32082699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracting drug-enzyme relation from literature as evidence for drug drug interaction.
    Zhang Y; Wu HY; Du J; Xu J; Wang J; Tao C; Li L; Xu H
    J Biomed Semantics; 2016; 7():11. PubMed ID: 26955465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How the Probability and Potential Clinical Significance of Pharmacokinetically Mediated Drug-Drug Interactions Are Assessed in Drug Development: Desvenlafaxine as an Example.
    Macaluso M; Nichols AI; Preskorn SH
    Prim Care Companion CNS Disord; 2015; 17(2):. PubMed ID: 26445693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting potential drug-drug interactions by integrating chemical, biological, phenotypic and network data.
    Zhang W; Chen Y; Liu F; Luo F; Tian G; Li X
    BMC Bioinformatics; 2017 Jan; 18(1):18. PubMed ID: 28056782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions caused by drug-drug interactions in cardiovascular disease patients: introduction of a simple prediction tool using electronic screening database items.
    Kovačević M; Vezmar Kovačević S; Radovanović S; Stevanović P; Miljković B
    Curr Med Res Opin; 2019 Nov; 35(11):1873-1883. PubMed ID: 31328967
    [No Abstract]   [Full Text] [Related]  

  • 18. National Rules for Drug-Drug Interactions: Are They Appropriate for Tertiary Hospitals?
    Cho I; Lee JH; Choi J; Hwang H; Bates DW
    J Korean Med Sci; 2016 Dec; 31(12):1887-1896. PubMed ID: 27822925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-Drug Interactions of P-gp Substrates Unrelated to CYP Metabolism.
    Akamine Y; Yasui-Furukori N; Uno T
    Curr Drug Metab; 2019; 20(2):124-129. PubMed ID: 30280663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting drug communities and predicting comprehensive drug-drug interactions via balance regularized semi-nonnegative matrix factorization.
    Shi JY; Mao KT; Yu H; Yiu SM
    J Cheminform; 2019 Apr; 11(1):28. PubMed ID: 30963300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.